⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SION News
Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
globenewswire.com
SION
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
globenewswire.com
SION
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference
globenewswire.com
SION